Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03343444
What this trial is testing

Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C Adolescents

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
Egyptian Liver Hospital 80
Post-approval studies (Phase 4)Ended earlyNCT00803309
What this trial is testing

Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients

Who this might be right for
Hepatitis C, Chronic
HepNet Study House, German Liverfoundation 99
Not applicableActive Not RecruitingNCT02995252
What this trial is testing

The HOPE Study: Characterizing Patients With Hepatitis B and C

Who this might be right for
Hepatitis B， ChronicHepatitis C
University of Maryland, Baltimore 550
Not applicableStudy completedNCT00724464
What this trial is testing

Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 332
Post-approval studies (Phase 4)Study completedNCT02781649
What this trial is testing

Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients

Who this might be right for
End-Stage Renal DiseaseHepatitis C
Johns Hopkins University 10
Large-scale testing (Phase 3)Study completedNCT00136318
What this trial is testing

Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected Patients

Who this might be right for
Depression
Charite University, Berlin, Germany 208
Early research (Phase 1)Study completedNCT01708889
What this trial is testing

Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction

Who this might be right for
Chronic Hepatitis B Virus InfectionChronic Hepatitis C Virus Infection
Bristol-Myers Squibb 43
Large-scale testing (Phase 3)WithdrawnNCT01517308
What this trial is testing

24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C

Who this might be right for
Chronic Hepatitis C
Federico II University
Large-scale testing (Phase 3)UnknownNCT04001608
What this trial is testing

Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients

Who this might be right for
Hepatitis C Virus Infection
Ginkgopharma CO., LTD 206
Not applicableStudy completedNCT03144440
What this trial is testing

Real World Experience of Chronic Hepatitis C (CHC) Treatment in Israel

Who this might be right for
Hepatitis C
Carmel Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT02243280
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 174
Post-approval studies (Phase 4)Study completedNCT07791940
What this trial is testing

Effect of Rifaximin on Thrombocytopenia in Patients With HCV-Related Liver Cirrhosis

Who this might be right for
Thrombocytopenia Related to Chronic Liver Disease
Fayoum University Hospital 200
Large-scale testing (Phase 3)Study completedNCT02939989
What this trial is testing

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Who this might be right for
Hepatitis C Virus Infection
AbbVie 33
Testing effectiveness (Phase 2)Study completedNCT01125189
What this trial is testing

Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 558
Large-scale testing (Phase 3)Study completedNCT02446717
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV+1 more
AbbVie 141
Testing effectiveness (Phase 2)Study completedNCT01273948
What this trial is testing

Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 Infection

Who this might be right for
Hepatitis C
Peregrine Pharmaceuticals 66
Not applicableUnknownNCT01146626
What this trial is testing

Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients?

Who this might be right for
Hepatitis C
Ziv Hospital 60
Large-scale testing (Phase 3)Study completedNCT00310336
What this trial is testing

Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine

Who this might be right for
Hepatitis C
University Hospital, Basel, Switzerland 30
Not applicableStudy completedNCT04352309
What this trial is testing

Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 99
Large-scale testing (Phase 3)Study completedNCT00004804
What this trial is testing

Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C

Who this might be right for
Hepatitis C
National Center for Research Resources (NCRR) 57
Next Page